European Commission approves label extension for Orkambi to include children aged 2-5 years Jan. 22, 2019
Data presented from 4-year follow-up of phase I/IIa study of NTCELL in Parkinson's disease Jan. 22, 2019
Results in patients with relapsed gastric cancer presented from the phase II MEDIOLA study Jan. 22, 2019
RSS